AU2014385276B2 - Isothiazole derivatives as GPR120 agonists for the treatment of Type II diabetes - Google Patents
Isothiazole derivatives as GPR120 agonists for the treatment of Type II diabetes Download PDFInfo
- Publication number
- AU2014385276B2 AU2014385276B2 AU2014385276A AU2014385276A AU2014385276B2 AU 2014385276 B2 AU2014385276 B2 AU 2014385276B2 AU 2014385276 A AU2014385276 A AU 2014385276A AU 2014385276 A AU2014385276 A AU 2014385276A AU 2014385276 B2 AU2014385276 B2 AU 2014385276B2
- Authority
- AU
- Australia
- Prior art keywords
- methoxy
- trifluoromethyl
- chloro
- phenyl
- fluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102100040134 Free fatty acid receptor 4 Human genes 0.000 title claims abstract description 41
- 101000890672 Homo sapiens Free fatty acid receptor 4 Proteins 0.000 title claims abstract description 41
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title claims description 44
- 238000011282 treatment Methods 0.000 title description 16
- 239000000556 agonist Substances 0.000 title description 9
- 150000003854 isothiazoles Chemical class 0.000 title description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 324
- 238000000034 method Methods 0.000 claims abstract description 203
- 239000000203 mixture Substances 0.000 claims abstract description 166
- 239000007787 solid Substances 0.000 claims description 258
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 248
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 201
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 169
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 claims description 129
- 235000019260 propionic acid Nutrition 0.000 claims description 129
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 120
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 106
- 125000001153 fluoro group Chemical group F* 0.000 claims description 94
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 90
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 81
- 125000001424 substituent group Chemical group 0.000 claims description 71
- -1 methoxy, fluoro, 1 fluoroethyl Chemical group 0.000 claims description 64
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 58
- 208000008589 Obesity Diseases 0.000 claims description 47
- 235000020824 obesity Nutrition 0.000 claims description 47
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 43
- 208000035475 disorder Diseases 0.000 claims description 40
- 150000003839 salts Chemical group 0.000 claims description 39
- 239000001257 hydrogen Substances 0.000 claims description 37
- 229910052739 hydrogen Inorganic materials 0.000 claims description 37
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 30
- 208000001145 Metabolic Syndrome Diseases 0.000 claims description 22
- 125000004076 pyridyl group Chemical group 0.000 claims description 20
- 239000008194 pharmaceutical composition Substances 0.000 claims description 18
- 206010022489 Insulin Resistance Diseases 0.000 claims description 17
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 17
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 16
- 125000004500 isothiazol-4-yl group Chemical group S1N=CC(=C1)* 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 15
- 239000008103 glucose Substances 0.000 claims description 15
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 15
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 14
- 208000032928 Dyslipidaemia Diseases 0.000 claims description 14
- 208000017170 Lipid metabolism disease Diseases 0.000 claims description 14
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 14
- 125000000335 thiazolyl group Chemical group 0.000 claims description 14
- 239000003085 diluting agent Substances 0.000 claims description 13
- 201000010390 abdominal obesity-metabolic syndrome 1 Diseases 0.000 claims description 12
- 208000011661 metabolic syndrome X Diseases 0.000 claims description 12
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 12
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 11
- 125000006002 1,1-difluoroethyl group Chemical group 0.000 claims description 10
- 206010014486 Elevated triglycerides Diseases 0.000 claims description 10
- 206010061218 Inflammation Diseases 0.000 claims description 10
- 208000001132 Osteoporosis Diseases 0.000 claims description 10
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims description 10
- 230000001771 impaired effect Effects 0.000 claims description 10
- 230000004054 inflammatory process Effects 0.000 claims description 10
- 239000003937 drug carrier Substances 0.000 claims description 7
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 6
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 125000001544 thienyl group Chemical group 0.000 claims description 6
- 125000001246 bromo group Chemical group Br* 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 125000004674 methylcarbonyl group Chemical group CC(=O)* 0.000 claims description 5
- GQJOCUJNVIBULK-UHFFFAOYSA-N 3-[3,5-difluoro-4-[[3-(1,2-thiazol-5-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoic acid Chemical compound FC=1C=C(C=C(C1OCC=1C(=NSC1C(F)(F)F)C1=CC=NS1)F)CCC(=O)O GQJOCUJNVIBULK-UHFFFAOYSA-N 0.000 claims description 3
- CSHPCGOCKUHMCH-UHFFFAOYSA-N 3-[3,5-difluoro-4-[[3-(5-methoxypyridin-2-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoic acid Chemical compound FC=1C=C(C=C(C1OCC=1C(=NSC1C(F)(F)F)C1=NC=C(C=C1)OC)F)CCC(=O)O CSHPCGOCKUHMCH-UHFFFAOYSA-N 0.000 claims description 3
- UYEQPRWGHIBZEO-UHFFFAOYSA-N 3-[4-[[3-(5-chloro-3-fluoropyridin-2-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3-fluorophenyl]-2-methylpropanoic acid Chemical compound ClC=1C=C(C(=NC1)C1=NSC(=C1COC1=C(C=C(C=C1)CC(C(=O)O)C)F)C(F)(F)F)F UYEQPRWGHIBZEO-UHFFFAOYSA-N 0.000 claims description 3
- VJWXNUJYSBEMQG-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2,4-dimethylphenyl)-1,2-thiazol-4-yl]methoxy]-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C(F)(F)F)C1=C(C=C(C=C1)C)C VJWXNUJYSBEMQG-UHFFFAOYSA-N 0.000 claims description 3
- JJAUKQBDNDYIQK-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C(F)(F)F)C1=C(C=CC=C1)Cl JJAUKQBDNDYIQK-UHFFFAOYSA-N 0.000 claims description 3
- BSMPDLWHEBDVSI-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-methoxyphenyl)-1,2-thiazol-4-yl]methoxy]-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C(F)(F)F)C1=C(C=CC=C1)OC BSMPDLWHEBDVSI-UHFFFAOYSA-N 0.000 claims description 3
- ZDMNBTYNNWONNS-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C(F)(F)F)C1=C(C=CC=C1)C ZDMNBTYNNWONNS-UHFFFAOYSA-N 0.000 claims description 3
- CRRPUBJWCVWNHT-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-2-methylphenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C)C1=C(C=CC=C1)C CRRPUBJWCVWNHT-UHFFFAOYSA-N 0.000 claims description 3
- KBSDNYOVHLKZSE-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-methylcyclohexen-1-yl)-1,2-thiazol-4-yl]methoxy]-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C(F)(F)F)C1=CCC(CC1)C KBSDNYOVHLKZSE-UHFFFAOYSA-N 0.000 claims description 3
- MDIISSRLFAQUKL-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-methylphenyl)-1,2-thiazol-4-yl]methoxy]-2-(1-fluoroethyl)phenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C(C)F)C1=CC=C(C=C1)C MDIISSRLFAQUKL-UHFFFAOYSA-N 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- UOYZSMXCWBVPFW-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2-(difluoromethyl)phenyl]propanoic acid Chemical compound ClC1=CC=C(C=C1)C1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C(F)F)C(F)(F)F UOYZSMXCWBVPFW-UHFFFAOYSA-N 0.000 claims description 2
- KEMJTSMZXNXNFK-UHFFFAOYSA-N 3-[4-[[3-(5-chloro-3-fluoropyridin-2-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoic acid Chemical compound ClC=1C=C(C(=NC1)C1=NSC(=C1COC1=C(C=C(C=C1F)CC(C(=O)O)C)F)C(F)(F)F)F KEMJTSMZXNXNFK-UHFFFAOYSA-N 0.000 claims description 2
- OKBOMPCMGSBYCO-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2,4-dimethylphenyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC=C(C=C1)CCC(=O)O)C1=C(C=C(C=C1)C)C OKBOMPCMGSBYCO-UHFFFAOYSA-N 0.000 claims description 2
- IXMBSHPTLQWCGL-UHFFFAOYSA-N 3-[7-[[3-chloro-5-(4-methylphenyl)-1,2-thiazol-4-yl]methoxy]-3,3-difluoro-1,2-dihydroinden-4-yl]propanoic acid Chemical compound ClC1=NSC(=C1COC=1C=CC(=C2C(CCC12)(F)F)CCC(=O)O)C1=CC=C(C=C1)C IXMBSHPTLQWCGL-UHFFFAOYSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 239000006186 oral dosage form Substances 0.000 claims description 2
- ZKRHLOKMNHLNFL-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-methylphenyl)-1,2-thiazol-4-yl]methoxy]-2-(1,1-difluoroethyl)phenyl]propanoic acid Chemical compound CC1=CC=C(C=C1)C1=C(COC2=CC(=C(CCC(O)=O)C=C2)C(C)(F)F)C(Cl)=NS1 ZKRHLOKMNHLNFL-UHFFFAOYSA-N 0.000 claims 1
- GFTODUORRZARMN-UHFFFAOYSA-N methyl 3-[4-[[3-(4-chloro-2-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoate Chemical compound ClC1=CC(=C(C=C1)C1=NSC(=C1COC1=C(C=C(C=C1F)CCC(=O)OC)F)C(F)(F)F)F GFTODUORRZARMN-UHFFFAOYSA-N 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 356
- 239000000243 solution Substances 0.000 description 250
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 192
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 180
- 239000000047 product Substances 0.000 description 169
- 238000001819 mass spectrum Methods 0.000 description 149
- 238000005481 NMR spectroscopy Methods 0.000 description 145
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 130
- 235000019439 ethyl acetate Nutrition 0.000 description 122
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 121
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 120
- 229940093499 ethyl acetate Drugs 0.000 description 112
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 104
- 230000007062 hydrolysis Effects 0.000 description 99
- 238000006460 hydrolysis reaction Methods 0.000 description 99
- 238000006243 chemical reaction Methods 0.000 description 96
- 239000003921 oil Substances 0.000 description 96
- 235000019198 oils Nutrition 0.000 description 96
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 88
- 239000003208 petroleum Substances 0.000 description 83
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 66
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 62
- 239000000741 silica gel Substances 0.000 description 62
- 229910002027 silica gel Inorganic materials 0.000 description 62
- 239000012044 organic layer Substances 0.000 description 61
- 230000008878 coupling Effects 0.000 description 56
- 239000007822 coupling agent Substances 0.000 description 56
- 238000010168 coupling process Methods 0.000 description 56
- 238000005859 coupling reaction Methods 0.000 description 56
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 54
- 229910052757 nitrogen Inorganic materials 0.000 description 54
- 239000012298 atmosphere Substances 0.000 description 49
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 39
- FRPDXOMKOVSTND-UHFFFAOYSA-N ethyl 3-(4-hydroxy-2,3-dimethylphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C(C)=C1C FRPDXOMKOVSTND-UHFFFAOYSA-N 0.000 description 37
- 238000003756 stirring Methods 0.000 description 35
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 33
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 31
- 239000002253 acid Substances 0.000 description 29
- IJAFUGGGBHSCAW-UHFFFAOYSA-N ethyl 3-(3,5-difluoro-4-hydroxyphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC(F)=C(O)C(F)=C1 IJAFUGGGBHSCAW-UHFFFAOYSA-N 0.000 description 28
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 26
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 24
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 23
- 230000009467 reduction Effects 0.000 description 23
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 21
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 20
- 239000007858 starting material Substances 0.000 description 19
- 238000004809 thin layer chromatography Methods 0.000 description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 201000010099 disease Diseases 0.000 description 18
- 238000005160 1H NMR spectroscopy Methods 0.000 description 17
- 239000000460 chlorine Chemical group 0.000 description 17
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 16
- 239000003960 organic solvent Substances 0.000 description 15
- 208000011580 syndromic disease Diseases 0.000 description 15
- BLNVISNJTIRAHF-UHFFFAOYSA-N 4-chlorobenzamide Chemical compound NC(=O)C1=CC=C(Cl)C=C1 BLNVISNJTIRAHF-UHFFFAOYSA-N 0.000 description 14
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 14
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 14
- 102100040918 Pro-glucagon Human genes 0.000 description 14
- 239000012230 colorless oil Substances 0.000 description 14
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 14
- 239000012074 organic phase Substances 0.000 description 14
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- 125000000217 alkyl group Chemical group 0.000 description 13
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 12
- 239000012267 brine Substances 0.000 description 12
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 12
- 239000012071 phase Substances 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 11
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 229910000027 potassium carbonate Inorganic materials 0.000 description 10
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 9
- 125000003118 aryl group Chemical group 0.000 description 9
- YJNYLZDLFQMZGR-UHFFFAOYSA-N ethyl 3-(2,3-difluoro-4-hydroxyphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C(F)=C1F YJNYLZDLFQMZGR-UHFFFAOYSA-N 0.000 description 9
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 9
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 8
- YKFAFWKDOSYQIP-UHFFFAOYSA-N 4-ethylbenzamide Chemical compound CCC1=CC=C(C(N)=O)C=C1 YKFAFWKDOSYQIP-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 230000008484 agonism Effects 0.000 description 8
- 229910000085 borane Inorganic materials 0.000 description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 8
- 239000003248 enzyme activator Substances 0.000 description 8
- 125000000623 heterocyclic group Chemical group 0.000 description 8
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 8
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 8
- 235000011181 potassium carbonates Nutrition 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000012453 solvate Substances 0.000 description 8
- ZPQOPVIELGIULI-UHFFFAOYSA-N 1,3-dichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1 ZPQOPVIELGIULI-UHFFFAOYSA-N 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 7
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 7
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- REZNQKBGCOTNER-UHFFFAOYSA-N ethyl 3-(3,5-difluoro-4-hydroxyphenyl)-2-methylpropanoate Chemical compound CCOC(=O)C(C)CC1=CC(F)=C(O)C(F)=C1 REZNQKBGCOTNER-UHFFFAOYSA-N 0.000 description 7
- 235000021588 free fatty acids Nutrition 0.000 description 7
- 125000001072 heteroaryl group Chemical group 0.000 description 7
- 125000005842 heteroatom Chemical group 0.000 description 7
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 6
- HRPBCNQKPJKETN-UHFFFAOYSA-N 4-chloro-3-fluorobenzamide Chemical compound NC(=O)C1=CC=C(Cl)C(F)=C1 HRPBCNQKPJKETN-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 6
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 6
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 6
- 230000003914 insulin secretion Effects 0.000 description 6
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 5
- NKEVOHSRGDFYKO-UHFFFAOYSA-N [3-(4-chlorophenyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound CS(=O)(=O)OCC1=CSN=C1C1=CC=C(Cl)C=C1 NKEVOHSRGDFYKO-UHFFFAOYSA-N 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 150000007942 carboxylates Chemical class 0.000 description 5
- 150000002431 hydrogen Chemical class 0.000 description 5
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 5
- 238000002953 preparative HPLC Methods 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 4
- GETTZEONDQJALK-UHFFFAOYSA-N (trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC=CC=C1 GETTZEONDQJALK-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 4
- WKAITTMZJQQYEI-UHFFFAOYSA-N 3,5-dichloro-1,2-thiazole-4-carboxylic acid Chemical compound OC(=O)C=1C(Cl)=NSC=1Cl WKAITTMZJQQYEI-UHFFFAOYSA-N 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 4
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 4
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 4
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 4
- 125000002619 bicyclic group Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 4
- 150000001721 carbon Chemical group 0.000 description 4
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 description 4
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 150000007529 inorganic bases Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 4
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 229940002612 prodrug Drugs 0.000 description 4
- 239000000651 prodrug Substances 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Substances C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- STCOOQWBFONSKY-UHFFFAOYSA-N tributyl phosphate Chemical compound CCCCOP(=O)(OCCCC)OCCCC STCOOQWBFONSKY-UHFFFAOYSA-N 0.000 description 4
- IDFPQEHZYBXIFO-GFCCVEGCSA-N (R)-(4-fluoro-2-propylphenyl)-(1H-imidazol-2-yl)methanol Chemical compound CCCc1cc(F)ccc1[C@@H](O)c1ncc[nH]1 IDFPQEHZYBXIFO-GFCCVEGCSA-N 0.000 description 3
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 3
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 3
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 3
- WAVNYPVYNSIHNC-UHFFFAOYSA-N 2-benzylidenepropanedinitrile Chemical compound N#CC(C#N)=CC1=CC=CC=C1 WAVNYPVYNSIHNC-UHFFFAOYSA-N 0.000 description 3
- APOYTRAZFJURPB-UHFFFAOYSA-N 2-methoxy-n-(2-methoxyethyl)-n-(trifluoro-$l^{4}-sulfanyl)ethanamine Chemical compound COCCN(S(F)(F)F)CCOC APOYTRAZFJURPB-UHFFFAOYSA-N 0.000 description 3
- HPKBQBQMXYLUBI-UHFFFAOYSA-N 3-(4-hydroxy-2,3-dimethylphenyl)propanoic acid Chemical compound CC1=C(C)C(CCC(O)=O)=CC=C1O HPKBQBQMXYLUBI-UHFFFAOYSA-N 0.000 description 3
- YCDMBFMRCWWHMP-UHFFFAOYSA-N 4-ethyl-2-fluorobenzamide Chemical compound CCC1=CC=C(C(N)=O)C(F)=C1 YCDMBFMRCWWHMP-UHFFFAOYSA-N 0.000 description 3
- LPSRKMGUAAQVQQ-UHFFFAOYSA-N 5-chloro-3-fluoropyridine-2-carboxamide Chemical compound NC(=O)C1=NC=C(Cl)C=C1F LPSRKMGUAAQVQQ-UHFFFAOYSA-N 0.000 description 3
- GDCYITYHSRWZES-UHFFFAOYSA-N 7-hydroxy-2,3-dihydro-1h-indene-4-carbaldehyde Chemical compound OC1=CC=C(C=O)C2=C1CCC2 GDCYITYHSRWZES-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 102000051325 Glucagon Human genes 0.000 description 3
- 108060003199 Glucagon Proteins 0.000 description 3
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- 235000019502 Orange oil Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- LXWOSNBOCQZKNX-UHFFFAOYSA-N [3-(4-bromophenyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound CS(=O)(=O)OCC1=CSN=C1C1=CC=C(Br)C=C1 LXWOSNBOCQZKNX-UHFFFAOYSA-N 0.000 description 3
- XUZSXTCZJKQFCU-UHFFFAOYSA-N [3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COS(C)(=O)=O XUZSXTCZJKQFCU-UHFFFAOYSA-N 0.000 description 3
- VHHNRYMUFKBNIC-UHFFFAOYSA-N [3-(5-chlorothiophen-2-yl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound CS(=O)(=O)OCC1=CSN=C1C1=CC=C(Cl)S1 VHHNRYMUFKBNIC-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 210000001072 colon Anatomy 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 125000004212 difluorophenyl group Chemical group 0.000 description 3
- HLUCIQKFFADSNI-UHFFFAOYSA-N ethyl 3-(2,3,5-trifluoro-4-hydroxyphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC(F)=C(O)C(F)=C1F HLUCIQKFFADSNI-UHFFFAOYSA-N 0.000 description 3
- PGFGDJRYGGZGOE-UHFFFAOYSA-N ethyl 3-(4-hydroxyphenyl)-2-methylpropanoate Chemical compound CCOC(=O)C(C)CC1=CC=C(O)C=C1 PGFGDJRYGGZGOE-UHFFFAOYSA-N 0.000 description 3
- TYFXKZPHONRDGW-UHFFFAOYSA-N ethyl 3-[2-fluoro-4-hydroxy-3-(trifluoromethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C(C(F)(F)F)=C1F TYFXKZPHONRDGW-UHFFFAOYSA-N 0.000 description 3
- LGTAETGNPOLTPJ-UHFFFAOYSA-N ethyl 3-[4-hydroxy-2-(trifluoromethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C=C1C(F)(F)F LGTAETGNPOLTPJ-UHFFFAOYSA-N 0.000 description 3
- GRTIVXSUDSEFSY-UHFFFAOYSA-N ethyl 4,4-difluoropent-2-ynoate Chemical compound CCOC(=O)C#CC(C)(F)F GRTIVXSUDSEFSY-UHFFFAOYSA-N 0.000 description 3
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 3
- 229960004666 glucagon Drugs 0.000 description 3
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 3
- 201000008980 hyperinsulinism Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 3
- 239000010502 orange oil Substances 0.000 description 3
- 150000007530 organic bases Chemical class 0.000 description 3
- 230000003389 potentiating effect Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- KKHTZDYYOZBASH-UHFFFAOYSA-N tert-butyl 3-(3,5-difluoro-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)OC(=O)CCC1=CC(F)=C(O)C(F)=C1 KKHTZDYYOZBASH-UHFFFAOYSA-N 0.000 description 3
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 3
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 3
- CBHRSTYUCOWLFC-UHFFFAOYSA-N (3,5-difluoro-4-hydroxyphenyl) propanoate Chemical compound CCC(=O)Oc1cc(F)c(O)c(F)c1 CBHRSTYUCOWLFC-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- BQCODZWYEJGCPT-UHFFFAOYSA-N 1-methoxy-2-methyl-3-(trifluoromethyl)benzene Chemical compound COC1=CC=CC(C(F)(F)F)=C1C BQCODZWYEJGCPT-UHFFFAOYSA-N 0.000 description 2
- XEZNGIUYQVAUSS-UHFFFAOYSA-N 18-crown-6 Chemical compound C1COCCOCCOCCOCCOCCO1 XEZNGIUYQVAUSS-UHFFFAOYSA-N 0.000 description 2
- 238000004293 19F NMR spectroscopy Methods 0.000 description 2
- KTXFXDMDYZIXSJ-UHFFFAOYSA-N 2,4-difluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C=C1F KTXFXDMDYZIXSJ-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- MVDRIMBGRZBWPE-UHFFFAOYSA-N 2-fluoro-4-methylbenzaldehyde Chemical compound CC1=CC=C(C=O)C(F)=C1 MVDRIMBGRZBWPE-UHFFFAOYSA-N 0.000 description 2
- CMWOHNIHUBDEAG-UHFFFAOYSA-N 3,4-difluorobenzamide Chemical compound NC(=O)C1=CC=C(F)C(F)=C1 CMWOHNIHUBDEAG-UHFFFAOYSA-N 0.000 description 2
- RUNARDFVMLWILC-UHFFFAOYSA-N 3,5-dichloro-1,2-thiazole-4-carbonitrile Chemical compound ClC1=NSC(Cl)=C1C#N RUNARDFVMLWILC-UHFFFAOYSA-N 0.000 description 2
- NYVIHTHXQDQZKM-UHFFFAOYSA-N 3,5-dichloro-1,2-thiazole-4-carboxamide Chemical compound NC(=O)C=1C(Cl)=NSC=1Cl NYVIHTHXQDQZKM-UHFFFAOYSA-N 0.000 description 2
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
- DWUZHQGLKGESKS-UHFFFAOYSA-N 3-(5-fluoro-4-hydroxy-2-methylphenyl)propanoic acid Chemical compound CC1=CC(O)=C(F)C=C1CCC(O)=O DWUZHQGLKGESKS-UHFFFAOYSA-N 0.000 description 2
- CFHJTBXNBIWPQK-UHFFFAOYSA-N 3-[3,5-difluoro-4-[[3-(6-methoxypyridin-3-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoic acid Chemical compound C1=NC(OC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CCC(O)=O)C=C1F CFHJTBXNBIWPQK-UHFFFAOYSA-N 0.000 description 2
- HVGBRPKMIGEUHG-UHFFFAOYSA-N 4-(chloromethyl)-5-ethenyl-3-(4-ethylphenyl)-1,2-thiazole Chemical compound C1=CC(CC)=CC=C1C1=NSC(C=C)=C1CCl HVGBRPKMIGEUHG-UHFFFAOYSA-N 0.000 description 2
- QCXJEYYXVJIFCE-UHFFFAOYSA-N 4-acetamidobenzoic acid Chemical compound CC(=O)NC1=CC=C(C(O)=O)C=C1 QCXJEYYXVJIFCE-UHFFFAOYSA-N 0.000 description 2
- WYCJKDFBALNGMP-UHFFFAOYSA-N 4-chloro-2,6-difluorobenzamide Chemical compound NC(=O)C1=C(F)C=C(Cl)C=C1F WYCJKDFBALNGMP-UHFFFAOYSA-N 0.000 description 2
- UVGYSEIWAOOIJR-UHFFFAOYSA-N 4-chloro-2-fluorobenzaldehyde Chemical compound FC1=CC(Cl)=CC=C1C=O UVGYSEIWAOOIJR-UHFFFAOYSA-N 0.000 description 2
- FBRCAMYSBQMVSU-UHFFFAOYSA-N 4-chloro-3-methoxybenzamide Chemical compound COC1=CC(C(N)=O)=CC=C1Cl FBRCAMYSBQMVSU-UHFFFAOYSA-N 0.000 description 2
- GXNHKNAIDAESFT-UHFFFAOYSA-N 4-ethyl-3-fluorobenzamide Chemical compound CCC1=CC=C(C(N)=O)C=C1F GXNHKNAIDAESFT-UHFFFAOYSA-N 0.000 description 2
- AYHOQZIMALPMHN-UHFFFAOYSA-N 4-methoxy-3,5-bis(trifluoromethyl)benzaldehyde Chemical compound COC1=C(C(F)(F)F)C=C(C=O)C=C1C(F)(F)F AYHOQZIMALPMHN-UHFFFAOYSA-N 0.000 description 2
- RROVLNCVGSZHCW-UHFFFAOYSA-N 4-methoxy-3,5-bis(trifluoromethyl)benzonitrile Chemical compound COC1=C(C(F)(F)F)C=C(C#N)C=C1C(F)(F)F RROVLNCVGSZHCW-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 229910015845 BBr3 Inorganic materials 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 2
- 102100026148 Free fatty acid receptor 1 Human genes 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 101000912510 Homo sapiens Free fatty acid receptor 1 Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- UHBGYFCCKRAEHA-UHFFFAOYSA-N P-toluamide Chemical compound CC1=CC=C(C(N)=O)C=C1 UHBGYFCCKRAEHA-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- UJYWLAALXLVJQH-UHFFFAOYSA-N [2-methoxy-6-(trifluoromethyl)phenyl]methanol Chemical compound COC1=CC=CC(C(F)(F)F)=C1CO UJYWLAALXLVJQH-UHFFFAOYSA-N 0.000 description 2
- TUMKXUQTANJIOO-UHFFFAOYSA-N [3-(2,6-difluoro-4-methoxyphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound FC1=CC(OC)=CC(F)=C1C1=NSC(C(F)(F)F)=C1COS(C)(=O)=O TUMKXUQTANJIOO-UHFFFAOYSA-N 0.000 description 2
- FERWEYXGNFYIKA-UHFFFAOYSA-N [3-(2-fluoro-4-methylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methanol Chemical compound FC1=CC(C)=CC=C1C1=NSC(C(F)(F)F)=C1CO FERWEYXGNFYIKA-UHFFFAOYSA-N 0.000 description 2
- JTGLVHZPGMPSHP-UHFFFAOYSA-N [3-(3-fluoro-4-methylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound C1=C(F)C(C)=CC=C1C1=NSC(C(F)(F)F)=C1COS(C)(=O)=O JTGLVHZPGMPSHP-UHFFFAOYSA-N 0.000 description 2
- OXNHTLXGVZCAQV-UHFFFAOYSA-N [3-(3-methoxyphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound COC1=CC=CC(C=2C(=C(SN=2)C(F)(F)F)COS(C)(=O)=O)=C1 OXNHTLXGVZCAQV-UHFFFAOYSA-N 0.000 description 2
- ZFDWRCZVCMWFIM-UHFFFAOYSA-N [3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methanol Chemical compound S1C(C(F)(F)F)=C(CO)C(C=2C=CC(Cl)=CC=2)=N1 ZFDWRCZVCMWFIM-UHFFFAOYSA-N 0.000 description 2
- IFERQEKIHKJDCM-UHFFFAOYSA-N [3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound S1C(C(F)(F)F)=C(COS(=O)(=O)C)C(C=2C=CC(Cl)=CC=2)=N1 IFERQEKIHKJDCM-UHFFFAOYSA-N 0.000 description 2
- UZVDDAHBPPROLY-UHFFFAOYSA-N [3-(4-methoxyphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound C1=CC(OC)=CC=C1C1=NSC(C(F)(F)F)=C1COS(C)(=O)=O UZVDDAHBPPROLY-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Substances CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 125000006001 difluoroethyl group Chemical group 0.000 description 2
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- CVSOIALBHUYCFX-GQCTYLIASA-N ethyl (E)-3-(2,3-difluoro-4-hydroxyphenyl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(O)C(F)=C1F CVSOIALBHUYCFX-GQCTYLIASA-N 0.000 description 2
- BJPJSCCHVLBWIN-ALCCZGGFSA-N ethyl (Z)-3-[2-fluoro-4-methoxy-3-(trifluoromethyl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C/C1=CC=C(OC)C(C(F)(F)F)=C1F BJPJSCCHVLBWIN-ALCCZGGFSA-N 0.000 description 2
- YATVIQKWGVBEJW-PLNGDYQASA-N ethyl (Z)-3-[4-methoxy-3,5-bis(trifluoromethyl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C/C1=CC(C(F)(F)F)=C(OC)C(C(F)(F)F)=C1 YATVIQKWGVBEJW-PLNGDYQASA-N 0.000 description 2
- CADWFYFGQXMTPM-SOFGYWHQSA-N ethyl (e)-3-[4-methoxy-3-methyl-2-(trifluoromethyl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(OC)C(C)=C1C(F)(F)F CADWFYFGQXMTPM-SOFGYWHQSA-N 0.000 description 2
- UTQUXHCCECBTHJ-UHFFFAOYSA-N ethyl 3-(4-hydroxy-1-benzothiophen-7-yl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C2=C1SC=C2 UTQUXHCCECBTHJ-UHFFFAOYSA-N 0.000 description 2
- GTRJZYVWIRYGQH-UHFFFAOYSA-N ethyl 3-(5-fluoro-4-hydroxy-2-methylphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC(F)=C(O)C=C1C GTRJZYVWIRYGQH-UHFFFAOYSA-N 0.000 description 2
- NSYQYPXICPYFPJ-UHFFFAOYSA-N ethyl 3-(7-hydroxy-2,3-dihydro-1h-inden-4-yl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C2=C1CCC2 NSYQYPXICPYFPJ-UHFFFAOYSA-N 0.000 description 2
- DWXGKSDEHBMCNE-UHFFFAOYSA-N ethyl 3-[2-fluoro-4-methoxy-3-(trifluoromethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC=C(OC)C(C(F)(F)F)=C1F DWXGKSDEHBMCNE-UHFFFAOYSA-N 0.000 description 2
- LFBHQPPPZPQFIT-UHFFFAOYSA-N ethyl 3-[4-hydroxy-3,5-bis(trifluoromethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC(C(F)(F)F)=C(O)C(C(F)(F)F)=C1 LFBHQPPPZPQFIT-UHFFFAOYSA-N 0.000 description 2
- SYBYECOZCLLVQY-UHFFFAOYSA-N ethyl 3-[4-hydroxy-3-methyl-2-(trifluoromethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C(C)=C1C(F)(F)F SYBYECOZCLLVQY-UHFFFAOYSA-N 0.000 description 2
- ZNGJHBJJBNVZJG-UHFFFAOYSA-N ethyl 3-[4-methoxy-3,5-bis(trifluoromethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC(C(F)(F)F)=C(OC)C(C(F)(F)F)=C1 ZNGJHBJJBNVZJG-UHFFFAOYSA-N 0.000 description 2
- IUJMHQRJVHUEOF-UHFFFAOYSA-N ethyl 3-[4-methoxy-3-methyl-2-(trifluoromethyl)phenyl]propanoate Chemical compound CCOC(=O)CCC1=CC=C(OC)C(C)=C1C(F)(F)F IUJMHQRJVHUEOF-UHFFFAOYSA-N 0.000 description 2
- SFDRHPQGYUYYNX-UHFFFAOYSA-N ethyl 4,4,4-trifluorobut-2-ynoate Chemical compound CCOC(=O)C#CC(F)(F)F SFDRHPQGYUYYNX-UHFFFAOYSA-N 0.000 description 2
- BPNVIQXAKVAZMC-UHFFFAOYSA-N ethyl 4,4,5,5,5-pentafluoropent-2-ynoate Chemical compound CCOC(=O)C#CC(F)(F)C(F)(F)F BPNVIQXAKVAZMC-UHFFFAOYSA-N 0.000 description 2
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 230000014101 glucose homeostasis Effects 0.000 description 2
- HHLFWLYXYJOTON-UHFFFAOYSA-N glyoxylic acid Chemical compound OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 238000011542 limb amputation Methods 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- ADUIVPFOAZXVOE-UHFFFAOYSA-N methyl 3,3-difluorocyclopentane-1-carboxylate Chemical compound COC(=O)C1CCC(F)(F)C1 ADUIVPFOAZXVOE-UHFFFAOYSA-N 0.000 description 2
- PNXMSIWJRHSLNO-UHFFFAOYSA-N methyl 3-(3-bromo-4-hydroxyphenyl)propanoate Chemical compound COC(=O)CCC1=CC=C(O)C(Br)=C1 PNXMSIWJRHSLNO-UHFFFAOYSA-N 0.000 description 2
- XRAMJHXWXCMGJM-UHFFFAOYSA-N methyl 3-(4-hydroxyphenyl)propionate Chemical compound COC(=O)CCC1=CC=C(O)C=C1 XRAMJHXWXCMGJM-UHFFFAOYSA-N 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 235000015320 potassium carbonate Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- LEHBURLTIWGHEM-UHFFFAOYSA-N pyridinium chlorochromate Chemical compound [O-][Cr](Cl)(=O)=O.C1=CC=[NH+]C=C1 LEHBURLTIWGHEM-UHFFFAOYSA-N 0.000 description 2
- MNOALXGAYUJNKX-UHFFFAOYSA-N s-chloro chloromethanethioate Chemical compound ClSC(Cl)=O MNOALXGAYUJNKX-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N thiocyanic acid Chemical compound SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- VJVZPTPOYCJFNI-UHFFFAOYSA-M (2-ethoxy-2-oxoethyl)-triphenylphosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CC(=O)OCC)C1=CC=CC=C1 VJVZPTPOYCJFNI-UHFFFAOYSA-M 0.000 description 1
- NSJVYHOPHZMZPN-UHFFFAOYSA-N (2-methylphenyl)boronic acid Chemical compound CC1=CC=CC=C1B(O)O NSJVYHOPHZMZPN-UHFFFAOYSA-N 0.000 description 1
- CMIBUZBMZCBCAT-HZPDHXFCSA-N (2r,3r)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid Chemical compound C1=CC(C)=CC=C1C(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(=O)C1=CC=C(C)C=C1 CMIBUZBMZCBCAT-HZPDHXFCSA-N 0.000 description 1
- GQPYTJVDPQTBQC-KLQYNRQASA-N (3r)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5h-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.C([C@H](CC(=O)N1CC=2N(C(=NN=2)C(F)(F)F)CC1)N)C1=CC(F)=C(F)C=C1F GQPYTJVDPQTBQC-KLQYNRQASA-N 0.000 description 1
- NQMRYYAAICMHPE-UHFFFAOYSA-N (4-methoxyphenyl)boron Chemical compound [B]C1=CC=C(OC)C=C1 NQMRYYAAICMHPE-UHFFFAOYSA-N 0.000 description 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 1
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 description 1
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- NJAXNMANHFABEJ-XBXARRHUSA-N (e)-3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]prop-2-enoic acid Chemical compound FC1=C(F)C(/C=C/C(=O)O)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 NJAXNMANHFABEJ-XBXARRHUSA-N 0.000 description 1
- HVSWDGGFTCDVHC-UXBLZVDNSA-N (e)-3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]prop-2-enoic acid Chemical compound CC1=C(C)C(\C=C\C(O)=O)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 HVSWDGGFTCDVHC-UXBLZVDNSA-N 0.000 description 1
- QFMUADHFADTWJK-LZCJLJQNSA-N (e)-3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]prop-2-enoic acid Chemical compound FC1=CC(/C=C/C(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 QFMUADHFADTWJK-LZCJLJQNSA-N 0.000 description 1
- KQLPPDVRINSGKV-XBXARRHUSA-N (e)-3-[4-[[3-chloro-5-(4-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]prop-2-enoic acid Chemical compound FC1=C(F)C(/C=C/C(=O)O)=CC=C1OCC1=C(C=2C=CC(Cl)=CC=2)SN=C1Cl KQLPPDVRINSGKV-XBXARRHUSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- HMVYYTRDXNKRBQ-UHFFFAOYSA-N 1,3-thiazole-4-carboxylic acid Chemical compound OC(=O)C1=CSC=N1 HMVYYTRDXNKRBQ-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- XANVIFOBBVAKCY-UHFFFAOYSA-N 1-bromo-2-fluoro-4-methoxybenzene Chemical compound COC1=CC=C(Br)C(F)=C1 XANVIFOBBVAKCY-UHFFFAOYSA-N 0.000 description 1
- SJJCQDRGABAVBB-UHFFFAOYSA-N 1-hydroxy-2-naphthoic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CC=C21 SJJCQDRGABAVBB-UHFFFAOYSA-N 0.000 description 1
- NBHKOXMOIRGJAI-UHFFFAOYSA-N 1-phenylbut-2-yne-1,4-diol Chemical compound OCC#CC(O)C1=CC=CC=C1 NBHKOXMOIRGJAI-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- XETRHNFRKCNWAJ-UHFFFAOYSA-N 2,2,3,3,3-pentafluoropropanoyl 2,2,3,3,3-pentafluoropropanoate Chemical compound FC(F)(F)C(F)(F)C(=O)OC(=O)C(F)(F)C(F)(F)F XETRHNFRKCNWAJ-UHFFFAOYSA-N 0.000 description 1
- SKJIOOPBFWKGTR-UHFFFAOYSA-N 2,3-bis(trifluoromethyl)benzonitrile Chemical compound FC(F)(F)C1=CC=CC(C#N)=C1C(F)(F)F SKJIOOPBFWKGTR-UHFFFAOYSA-N 0.000 description 1
- CEBLXNZWBXVSKR-UHFFFAOYSA-N 2,4,6-trichlorobenzamide Chemical compound NC(=O)C1=C(Cl)C=C(Cl)C=C1Cl CEBLXNZWBXVSKR-UHFFFAOYSA-N 0.000 description 1
- YFTHTJAPODJVSL-UHFFFAOYSA-N 2-(1-benzothiophen-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(SC=C2)C2=C1 YFTHTJAPODJVSL-UHFFFAOYSA-N 0.000 description 1
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 1
- AUGMAJDEQVZJGV-UHFFFAOYSA-N 2-(chloromethyl)-1-methoxy-3-(trifluoromethyl)benzene Chemical compound COC1=CC=CC(C(F)(F)F)=C1CCl AUGMAJDEQVZJGV-UHFFFAOYSA-N 0.000 description 1
- ZHZJTIIRJIZFDG-UHFFFAOYSA-N 2-(difluoromethyl)-2-hydroxy-6-methyl-3h-chromen-4-one Chemical compound O1C(O)(C(F)F)CC(=O)C2=CC(C)=CC=C21 ZHZJTIIRJIZFDG-UHFFFAOYSA-N 0.000 description 1
- KKFDCBRMNNSAAW-UHFFFAOYSA-N 2-(morpholin-4-yl)ethanol Chemical compound OCCN1CCOCC1 KKFDCBRMNNSAAW-UHFFFAOYSA-N 0.000 description 1
- KQUXXJMMRODTQF-UHFFFAOYSA-N 2-[(2-methylphenyl)methylidene]propanedinitrile Chemical compound CC1=CC=CC=C1C=C(C#N)C#N KQUXXJMMRODTQF-UHFFFAOYSA-N 0.000 description 1
- WKAVKKUXZAWHDM-UHFFFAOYSA-N 2-acetamidopentanedioic acid;2-(dimethylamino)ethanol Chemical compound CN(C)CCO.CC(=O)NC(C(O)=O)CCC(O)=O WKAVKKUXZAWHDM-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- XMOIUWZSRNXGQZ-UHFFFAOYSA-N 2-fluoro-4-methoxy-3-(trifluoromethyl)benzaldehyde Chemical compound COC1=CC=C(C=O)C(F)=C1C(F)(F)F XMOIUWZSRNXGQZ-UHFFFAOYSA-N 0.000 description 1
- UDWWLZPFOGNOJD-UHFFFAOYSA-N 2-hydroxy-2-(4-hydroxy-1-benzothiophen-7-yl)acetic acid Chemical compound OC(=O)C(O)C1=CC=C(O)C2=C1SC=C2 UDWWLZPFOGNOJD-UHFFFAOYSA-N 0.000 description 1
- IOJYMQXQDCJQBF-UHFFFAOYSA-N 2-methoxy-6-(trifluoromethyl)benzoic acid Chemical compound COC1=CC=CC(C(F)(F)F)=C1C(O)=O IOJYMQXQDCJQBF-UHFFFAOYSA-N 0.000 description 1
- YNJXVWIPWJKJJD-UHFFFAOYSA-N 2-methoxypyridine-3-carboxamide Chemical compound COC1=NC=CC=C1C(N)=O YNJXVWIPWJKJJD-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- IVXXDPVAMNAKIB-UHFFFAOYSA-N 3,3-difluorocyclopentane-1-carboxamide Chemical compound NC(=O)C1CCC(F)(F)C1 IVXXDPVAMNAKIB-UHFFFAOYSA-N 0.000 description 1
- KIFMDBYGVLUROH-UHFFFAOYSA-N 3-(3-fluoro-4-hydroxyphenyl)-2-methylpropanoic acid Chemical compound OC(=O)C(C)CC1=CC=C(O)C(F)=C1 KIFMDBYGVLUROH-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- XKTZQEBTUDDXNU-UHFFFAOYSA-N 3-[3,5-difluoro-4-[[3-(oxolan-3-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1COCC1 XKTZQEBTUDDXNU-UHFFFAOYSA-N 0.000 description 1
- XUHRXSDKGXPQFW-UHFFFAOYSA-N 3-[3,5-difluoro-4-[[3-phenyl-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=CC=C1 XUHRXSDKGXPQFW-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- KOHMUAMPZUHGNV-UHFFFAOYSA-N 3-[4-[(5-chloro-2,2-dimethyl-3h-1-benzofuran-7-yl)methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC=2C=3OC(C)(C)CC=3C=C(Cl)C=2)=C1 KOHMUAMPZUHGNV-UHFFFAOYSA-N 0.000 description 1
- VECHELLAEBUYMV-UHFFFAOYSA-N 3-[4-[[3-(2,4-difluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoic acid Chemical compound FC1=CC(CC(C)C(O)=O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(F)C=C1F VECHELLAEBUYMV-UHFFFAOYSA-N 0.000 description 1
- FOJIUDKDBOQCQW-UHFFFAOYSA-N 3-[4-[[3-(2,4-difluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(F)C=C1F FOJIUDKDBOQCQW-UHFFFAOYSA-N 0.000 description 1
- WPVHWFLLVQKNJZ-UHFFFAOYSA-N 3-[4-[[3-(3,4-difluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC2=C(SN=C2C=2C=C(F)C(F)=CC=2)C(F)(F)F)=C1 WPVHWFLLVQKNJZ-UHFFFAOYSA-N 0.000 description 1
- ZCOUKMZVTYKJML-UHFFFAOYSA-N 3-[4-[[3-(3,4-difluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(F)C(F)=C1 ZCOUKMZVTYKJML-UHFFFAOYSA-N 0.000 description 1
- AOHLROQKSISOKG-UHFFFAOYSA-N 3-[4-[[3-(4-bromophenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoic acid Chemical compound FC1=C(F)C(CCC(=O)O)=CC=C1OCC1=CSN=C1C1=CC=C(Br)C=C1 AOHLROQKSISOKG-UHFFFAOYSA-N 0.000 description 1
- BRSIGKWQQNZOMF-UHFFFAOYSA-N 3-[4-[[3-(4-bromophenyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC=2C(=NSC=2)C=2C=CC(Br)=CC=2)=C1 BRSIGKWQQNZOMF-UHFFFAOYSA-N 0.000 description 1
- USKPSTGLOPGPDJ-UHFFFAOYSA-N 3-[4-[[3-(4-bromophenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=CSN=C1C1=CC=C(Br)C=C1 USKPSTGLOPGPDJ-UHFFFAOYSA-N 0.000 description 1
- BSMCZDWAZWYWFQ-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-2,6-difluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=C(F)C=C(Cl)C=C1F BSMCZDWAZWYWFQ-UHFFFAOYSA-N 0.000 description 1
- VWDHXIAKGCMCDJ-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-2,6-difluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-methylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=CC(OCC2=C(SN=C2C=2C(=CC(Cl)=CC=2F)F)C(F)(F)F)=C1F VWDHXIAKGCMCDJ-UHFFFAOYSA-N 0.000 description 1
- PSUHZRYVUSVFCF-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-2-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1F PSUHZRYVUSVFCF-UHFFFAOYSA-N 0.000 description 1
- YQUBWHIQXIQIGZ-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-3-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC2=C(SN=C2C=2C=C(F)C(Cl)=CC=2)C(F)(F)F)=C1 YQUBWHIQXIQIGZ-UHFFFAOYSA-N 0.000 description 1
- ZHVGMPUBFMPJJQ-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-3-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoic acid Chemical compound FC1=CC(CC(C)C(O)=O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C(F)=C1 ZHVGMPUBFMPJJQ-UHFFFAOYSA-N 0.000 description 1
- WDBDYYZRGDMJMJ-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-3-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C(F)=C1 WDBDYYZRGDMJMJ-UHFFFAOYSA-N 0.000 description 1
- FNVAGSOGANAPDK-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-3-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-methylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=CC(OCC2=C(SN=C2C=2C=C(F)C(Cl)=CC=2)C(F)(F)F)=C1F FNVAGSOGANAPDK-UHFFFAOYSA-N 0.000 description 1
- MNPAJHMZSXWAKG-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-3-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]-2-methylpropanoic acid Chemical compound C1=CC(CC(C)C(O)=O)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C(F)=C1 MNPAJHMZSXWAKG-UHFFFAOYSA-N 0.000 description 1
- IBNZEOCMVMZNCM-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-3-methoxyphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(Cl)C(OC)=CC(C=2C(=C(SN=2)C(F)(F)F)COC=2C(=C(C)C(CCC(O)=O)=CC=2)C)=C1 IBNZEOCMVMZNCM-UHFFFAOYSA-N 0.000 description 1
- BKPPVSVJVCPGTG-UHFFFAOYSA-N 3-[4-[[3-(4-chloro-3-methoxyphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound C1=C(Cl)C(OC)=CC(C=2C(=C(SN=2)C(F)(F)F)COC=2C(=CC(CCC(O)=O)=CC=2F)F)=C1 BKPPVSVJVCPGTG-UHFFFAOYSA-N 0.000 description 1
- APEFKOSSPFIZMB-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoic acid Chemical compound FC1=C(F)C(CCC(=O)O)=CC=C1OCC1=CSN=C1C1=CC=C(Cl)C=C1 APEFKOSSPFIZMB-UHFFFAOYSA-N 0.000 description 1
- TWJRALVZUZRXFS-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC=2C(=NSC=2)C=2C=CC(Cl)=CC=2)=C1 TWJRALVZUZRXFS-UHFFFAOYSA-N 0.000 description 1
- HLVBLRXPQXQBOG-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluoro-2-methylphenyl]propanoic acid Chemical compound CC1=C(CCC(O)=O)C=C(F)C(OCC=2C(=NSC=2)C=2C=CC(Cl)=CC=2)=C1F HLVBLRXPQXQBOG-UHFFFAOYSA-N 0.000 description 1
- RXIMHDCTQHIKLM-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=CSN=C1C1=CC=C(Cl)C=C1 RXIMHDCTQHIKLM-UHFFFAOYSA-N 0.000 description 1
- SRXGZCPFUAZDEA-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3,5,6-tetrafluorophenyl]propanoic acid Chemical compound FC1=C(F)C(CCC(=O)O)=C(F)C(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 SRXGZCPFUAZDEA-UHFFFAOYSA-N 0.000 description 1
- PVNAWYXFTDKNNE-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3,5-trifluorophenyl]propanoic acid Chemical compound FC1=C(F)C(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 PVNAWYXFTDKNNE-UHFFFAOYSA-N 0.000 description 1
- FXDLRMDATPUIFL-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propan-1-ol Chemical compound FC1=C(F)C(CCCO)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 FXDLRMDATPUIFL-UHFFFAOYSA-N 0.000 description 1
- QJIWWRJZWUKPJY-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2-methylphenyl]propanoic acid Chemical compound ClC1=CC=C(C=C1)C1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)C)C(F)(F)F QJIWWRJZWUKPJY-UHFFFAOYSA-N 0.000 description 1
- HWIVATUHIQJXRT-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluoro-2-methylphenyl]propan-1-ol Chemical compound CC1=C(CCCO)C=C(F)C(OCC2=C(SN=C2C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1F HWIVATUHIQJXRT-UHFFFAOYSA-N 0.000 description 1
- VJJZBANOLIEKON-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluoro-2-methylphenyl]propanoic acid Chemical compound CC1=C(CCC(O)=O)C=C(F)C(OCC2=C(SN=C2C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1F VJJZBANOLIEKON-UHFFFAOYSA-N 0.000 description 1
- IKXFFUGORPYWTP-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoic acid Chemical compound FC1=CC(CC(C)C(O)=O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 IKXFFUGORPYWTP-UHFFFAOYSA-N 0.000 description 1
- CWIOCWPBIJDWLI-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-methylphenyl]propan-1-ol Chemical compound C1=C(CCCO)C(C)=CC(OCC2=C(SN=C2C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1F CWIOCWPBIJDWLI-UHFFFAOYSA-N 0.000 description 1
- RPOJRRAPBWAVPF-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-methylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=CC(OCC2=C(SN=C2C=2C=CC(Cl)=CC=2)C(F)(F)F)=C1F RPOJRRAPBWAVPF-UHFFFAOYSA-N 0.000 description 1
- QZOZXOUCDZAMOD-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]-2-methylpropanoic acid Chemical compound C1=CC(CC(C)C(O)=O)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 QZOZXOUCDZAMOD-UHFFFAOYSA-N 0.000 description 1
- ZTHWBUWDBMAGOJ-UHFFFAOYSA-N 3-[4-[[3-(4-chlorophenyl)-5-methyl-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoic acid Chemical compound CC=1SN=C(C=2C=CC(Cl)=CC=2)C=1COC1=CC=C(CCC(O)=O)C(F)=C1F ZTHWBUWDBMAGOJ-UHFFFAOYSA-N 0.000 description 1
- HNYQVJLQRVUHLH-UHFFFAOYSA-N 3-[4-[[3-(4-cyanophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound C(#N)C1=CC=C(C=C1)C1=NSC(=C1COC1=C(C=C(C=C1F)CCC(=O)O)F)C(F)(F)F HNYQVJLQRVUHLH-UHFFFAOYSA-N 0.000 description 1
- ASEXCRCQMBGDEM-UHFFFAOYSA-N 3-[4-[[3-(4-cyclopropylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC2=C(SN=C2C=2C=CC(=CC=2)C2CC2)C(F)(F)F)=C1 ASEXCRCQMBGDEM-UHFFFAOYSA-N 0.000 description 1
- MRVMLCOMMXGCLS-UHFFFAOYSA-N 3-[4-[[3-(4-ethyl-2-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound FC1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=CC=C(CCC(O)=O)C(C)=C1C MRVMLCOMMXGCLS-UHFFFAOYSA-N 0.000 description 1
- HHLOIBUWAJPFKE-UHFFFAOYSA-N 3-[4-[[3-(4-ethyl-2-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoic acid Chemical compound FC1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CC(C)C(O)=O)C=C1F HHLOIBUWAJPFKE-UHFFFAOYSA-N 0.000 description 1
- YGIMMAAPQOVENC-UHFFFAOYSA-N 3-[4-[[3-(4-ethyl-2-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CCC(O)=O)C=C1F YGIMMAAPQOVENC-UHFFFAOYSA-N 0.000 description 1
- UDMUKQHQFDHMPL-UHFFFAOYSA-N 3-[4-[[3-(4-ethyl-3-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoic acid Chemical compound C1=C(F)C(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CC(C)C(O)=O)C=C1F UDMUKQHQFDHMPL-UHFFFAOYSA-N 0.000 description 1
- MLBJEBPMGKLDSB-UHFFFAOYSA-N 3-[4-[[3-(4-ethyl-3-fluorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound C1=C(F)C(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CCC(O)=O)C=C1F MLBJEBPMGKLDSB-UHFFFAOYSA-N 0.000 description 1
- BQCDIZZHLAYRDM-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3,5,6-tetrafluorophenyl]propanoic acid Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C(F)=C(CCC(O)=O)C(F)=C1F BQCDIZZHLAYRDM-UHFFFAOYSA-N 0.000 description 1
- PCJGQXLNDXPABW-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3,5-trifluorophenyl]propan-1-ol Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CCCO)C(F)=C1F PCJGQXLNDXPABW-UHFFFAOYSA-N 0.000 description 1
- YTYPFCMPDWSTHI-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3,5-trifluorophenyl]propanoic acid Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CCC(O)=O)C(F)=C1F YTYPFCMPDWSTHI-UHFFFAOYSA-N 0.000 description 1
- DGNSAWFTEVANDS-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propan-1-ol Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=CC=C(CCCO)C(F)=C1F DGNSAWFTEVANDS-UHFFFAOYSA-N 0.000 description 1
- ZTUVDBLZDLCMOL-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoic acid Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=CC=C(CCC(O)=O)C(F)=C1F ZTUVDBLZDLCMOL-UHFFFAOYSA-N 0.000 description 1
- MSWGCCITFKPGSX-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propan-1-ol Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(F)C=C(CCCO)C=C1F MSWGCCITFKPGSX-UHFFFAOYSA-N 0.000 description 1
- AFQXYHCQLWSESQ-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-dimethylphenyl]propanoic acid Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=C(C)C=C(CCC(O)=O)C=C1C AFQXYHCQLWSESQ-UHFFFAOYSA-N 0.000 description 1
- PIOXYDNVZDOGFH-UHFFFAOYSA-N 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3-fluorophenyl]-2-methylpropanoic acid Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1COC1=CC=C(CC(C)C(O)=O)C=C1F PIOXYDNVZDOGFH-UHFFFAOYSA-N 0.000 description 1
- LXMQKPOKKOINMJ-UHFFFAOYSA-N 3-[4-[[3-(4-ethynylphenyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC=2C(=NSC=2)C=2C=CC(=CC=2)C#C)=C1 LXMQKPOKKOINMJ-UHFFFAOYSA-N 0.000 description 1
- XETMYIFZPIJZNR-UHFFFAOYSA-N 3-[4-[[3-(5-chloro-3-fluoropyridin-2-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC2=C(SN=C2C=2C(=CC(Cl)=CN=2)F)C(F)(F)F)=C1 XETMYIFZPIJZNR-UHFFFAOYSA-N 0.000 description 1
- RIXHMRHWSZGKJZ-UHFFFAOYSA-N 3-[4-[[3-(5-chloro-3-fluoropyridin-2-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=NC=C(Cl)C=C1F RIXHMRHWSZGKJZ-UHFFFAOYSA-N 0.000 description 1
- DWUJRWNWJBUOGA-UHFFFAOYSA-N 3-[4-[[3-(5-chloro-3-fluoropyridin-2-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-methylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=CC(OCC2=C(SN=C2C=2C(=CC(Cl)=CN=2)F)C(F)(F)F)=C1F DWUJRWNWJBUOGA-UHFFFAOYSA-N 0.000 description 1
- WANWQDLXFHWERB-UHFFFAOYSA-N 3-[4-[[3-(5-chloropyridin-2-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=N1 WANWQDLXFHWERB-UHFFFAOYSA-N 0.000 description 1
- JOWAGFOVHXVKOO-UHFFFAOYSA-N 3-[4-[[3-(5-chlorothiophen-2-yl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoic acid Chemical compound FC1=C(F)C(CCC(=O)O)=CC=C1OCC1=CSN=C1C1=CC=C(Cl)S1 JOWAGFOVHXVKOO-UHFFFAOYSA-N 0.000 description 1
- ANLXALDYYGOAHY-UHFFFAOYSA-N 3-[4-[[3-(5-chlorothiophen-2-yl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(C)=C(C)C(OCC=2C(=NSC=2)C=2SC(Cl)=CC=2)=C1 ANLXALDYYGOAHY-UHFFFAOYSA-N 0.000 description 1
- BZUDYEVULRCHNE-UHFFFAOYSA-N 3-[4-[[3-(5-chlorothiophen-2-yl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=CSN=C1C1=CC=C(Cl)S1 BZUDYEVULRCHNE-UHFFFAOYSA-N 0.000 description 1
- FKJZUQHOMBIOFD-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-fluoro-4-methylphenyl)-1,2-thiazol-4-yl]methoxy]-2-methoxyphenyl]propanoic acid Chemical compound ClC1=NSC(=C1COC1=CC(=C(C=C1)CCC(=O)O)OC)C1=C(C=C(C=C1)C)F FKJZUQHOMBIOFD-UHFFFAOYSA-N 0.000 description 1
- QFFDEQGPXBSVNX-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-fluoro-4-methylphenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(C)=CC=C1C1=C(COC=2C(=CC(CCC(O)=O)=CC=2F)F)C(Cl)=NS1 QFFDEQGPXBSVNX-UHFFFAOYSA-N 0.000 description 1
- WSYLXRMOVHMVTD-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-2-methoxyphenyl]propanoic acid Chemical compound C1=C(CCC(O)=O)C(OC)=CC(OCC2=C(SN=C2Cl)C=2C(=CC=CC=2)C)=C1 WSYLXRMOVHMVTD-UHFFFAOYSA-N 0.000 description 1
- DLULSLFRJCELMK-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-5-ethyl-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound CCC1=CC(CCC(O)=O)=C(C(F)(F)F)C=C1OCC1=C(C=2C(=CC=CC=2)C)SN=C1Cl DLULSLFRJCELMK-UHFFFAOYSA-N 0.000 description 1
- UODHRAFCTQNLMD-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound CC1=CC=CC=C1C1=C(COC=2C(=CC(CCC(O)=O)=C(C=2)C(F)(F)F)F)C(Cl)=NS1 UODHRAFCTQNLMD-UHFFFAOYSA-N 0.000 description 1
- GDCULFRQABVYLQ-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-5-methyl-2-(trifluoromethyl)phenyl]propanoic acid Chemical compound CC1=CC(CCC(O)=O)=C(C(F)(F)F)C=C1OCC1=C(C=2C(=CC=CC=2)C)SN=C1Cl GDCULFRQABVYLQ-UHFFFAOYSA-N 0.000 description 1
- FBRLHOABQLVOKF-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-chloro-2-fluorophenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoic acid Chemical compound FC1=CC(CCC(=O)O)=CC(F)=C1OCC1=C(C=2C(=CC(Cl)=CC=2)F)SN=C1Cl FBRLHOABQLVOKF-UHFFFAOYSA-N 0.000 description 1
- REAWLBHRITZHFI-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propan-1-ol Chemical compound FC1=C(F)C(CCCO)=CC=C1OCC1=C(C=2C=CC(Cl)=CC=2)SN=C1Cl REAWLBHRITZHFI-UHFFFAOYSA-N 0.000 description 1
- AVQMAIRNRYGKSG-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-ethylphenyl)-1,2-thiazol-4-yl]methoxy]-2,3,5-trifluorophenyl]propan-1-ol Chemical compound C1=CC(CC)=CC=C1C1=C(COC=2C(=C(F)C(CCCO)=CC=2F)F)C(Cl)=NS1 AVQMAIRNRYGKSG-UHFFFAOYSA-N 0.000 description 1
- VPZYLMPYJKOCQR-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-ethylphenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propan-1-ol Chemical compound C1=CC(CC)=CC=C1C1=C(COC=2C(=C(F)C(CCCO)=CC=2)F)C(Cl)=NS1 VPZYLMPYJKOCQR-UHFFFAOYSA-N 0.000 description 1
- IGTMIZAPBGPMON-UHFFFAOYSA-N 3-[4-[[3-chloro-5-(4-ethylphenyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoic acid Chemical compound C1=CC(CC)=CC=C1C1=C(COC=2C(=C(C)C(CCC(O)=O)=CC=2)C)C(Cl)=NS1 IGTMIZAPBGPMON-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-M 3-carboxy-2,3-dihydroxypropanoate Chemical compound OC(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-M 0.000 description 1
- ALKYHXVLJMQRLQ-UHFFFAOYSA-M 3-carboxynaphthalen-2-olate Chemical compound C1=CC=C2C=C(C([O-])=O)C(O)=CC2=C1 ALKYHXVLJMQRLQ-UHFFFAOYSA-M 0.000 description 1
- AXPZSYDMQJLXMQ-UHFFFAOYSA-N 3-chloro-4-(chloromethyl)-5-(4-ethylphenyl)-1,2-thiazole Chemical compound C1=CC(CC)=CC=C1C1=C(CCl)C(Cl)=NS1 AXPZSYDMQJLXMQ-UHFFFAOYSA-N 0.000 description 1
- WENWLKRBTDLBEA-UHFFFAOYSA-N 3-chloro-4-(chloromethyl)-5-(4-methoxyphenyl)-1,2-thiazole Chemical compound C1=CC(OC)=CC=C1C1=C(CCl)C(Cl)=NS1 WENWLKRBTDLBEA-UHFFFAOYSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- CLQASPKCRDAKSG-UHFFFAOYSA-N 3-methyl-1,2-thiazole-4-carbonitrile Chemical compound CC1=NSC=C1C#N CLQASPKCRDAKSG-UHFFFAOYSA-N 0.000 description 1
- RDSNBKRWKBMPOP-UHFFFAOYSA-N 3-oxocyclopentanecarboxylic acid Chemical compound OC(=O)C1CCC(=O)C1 RDSNBKRWKBMPOP-UHFFFAOYSA-N 0.000 description 1
- QTRJTMPLVIRDHO-UHFFFAOYSA-N 3-phenyl-1,2-thiazole Chemical compound S1C=CC(C=2C=CC=CC=2)=N1 QTRJTMPLVIRDHO-UHFFFAOYSA-N 0.000 description 1
- 125000004364 3-pyrrolinyl group Chemical group [H]C1=C([H])C([H])([H])N(*)C1([H])[H] 0.000 description 1
- XYGSSOQVQKSCOK-UHFFFAOYSA-N 4,4,4-trifluorobut-2-ynoic acid Chemical compound OC(=O)C#CC(F)(F)F XYGSSOQVQKSCOK-UHFFFAOYSA-N 0.000 description 1
- HPDVATKYEPRUII-UHFFFAOYSA-N 4,4,5,5,5-pentafluoropent-2-ynoic acid Chemical compound FC(C(C#CC(=O)O)(F)F)(F)F HPDVATKYEPRUII-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- MUBFCNVVMSVQRB-UHFFFAOYSA-N 4-(chloromethyl)-3-(4-ethylphenyl)-5-prop-1-en-2-yl-1,2-thiazole Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(C)=C)=C1CCl MUBFCNVVMSVQRB-UHFFFAOYSA-N 0.000 description 1
- BEOBZEOPTQQELP-UHFFFAOYSA-N 4-(trifluoromethyl)benzaldehyde Chemical compound FC(F)(F)C1=CC=C(C=O)C=C1 BEOBZEOPTQQELP-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 1
- GPRPSJPFAAGLCA-UHFFFAOYSA-N 4-bromo-2,6-difluorophenol Chemical compound OC1=C(F)C=C(Br)C=C1F GPRPSJPFAAGLCA-UHFFFAOYSA-N 0.000 description 1
- MRQYTJXVULSNIS-UHFFFAOYSA-N 4-bromo-3-fluorophenol Chemical compound OC1=CC=C(Br)C(F)=C1 MRQYTJXVULSNIS-UHFFFAOYSA-N 0.000 description 1
- ISXNTFNVBYPXMO-UHFFFAOYSA-N 4-chloro-2-fluorobenzamide Chemical compound NC(=O)C1=CC=C(Cl)C=C1F ISXNTFNVBYPXMO-UHFFFAOYSA-N 0.000 description 1
- TUWQECDDVRORJX-UHFFFAOYSA-N 4-chloro-3,5-bis(trifluoromethyl)benzonitrile Chemical compound FC(F)(F)C1=CC(C#N)=CC(C(F)(F)F)=C1Cl TUWQECDDVRORJX-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- SBXKNWUHGXAYII-UHFFFAOYSA-N 4-cyclopropylbenzamide Chemical compound C1=CC(C(=O)N)=CC=C1C1CC1 SBXKNWUHGXAYII-UHFFFAOYSA-N 0.000 description 1
- UOQXIWFBQSVDPP-UHFFFAOYSA-N 4-fluorobenzaldehyde Chemical compound FC1=CC=C(C=O)C=C1 UOQXIWFBQSVDPP-UHFFFAOYSA-N 0.000 description 1
- JXQGDDMZTWHASG-UHFFFAOYSA-N 4-hydroxy-1-benzothiophene-7-carbaldehyde Chemical compound OC1=CC=C(C=O)C2=C1C=CS2 JXQGDDMZTWHASG-UHFFFAOYSA-N 0.000 description 1
- LORPDGZOLAPNHP-UHFFFAOYSA-N 4-hydroxynaphthalene-1-carbaldehyde Chemical compound C1=CC=C2C(O)=CC=C(C=O)C2=C1 LORPDGZOLAPNHP-UHFFFAOYSA-N 0.000 description 1
- MAUCRURSQMOFGV-UHFFFAOYSA-N 4-propylbenzaldehyde Chemical compound CCCC1=CC=C(C=O)C=C1 MAUCRURSQMOFGV-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- HTQBXNHDCUEHJF-XWLPCZSASA-N Exenatide Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 HTQBXNHDCUEHJF-XWLPCZSASA-N 0.000 description 1
- 108010011459 Exenatide Proteins 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000003790 Foot Ulcer Diseases 0.000 description 1
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 description 1
- 102000007446 Glucagon-Like Peptide-1 Receptor Human genes 0.000 description 1
- 108010086246 Glucagon-Like Peptide-1 Receptor Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 101100227062 Mus musculus Ffar4 gene Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
- 102000003923 Protein Kinase C Human genes 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 101100227063 Rattus norvegicus Ffar4 gene Proteins 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 238000006619 Stille reaction Methods 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920002253 Tannate Polymers 0.000 description 1
- 208000032109 Transient ischaemic attack Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- ZUSWDTWYONAOPH-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]hydrazine;hydrochloride Chemical group [Cl-].[NH3+]NC1=CC=CC=C1C(F)(F)F ZUSWDTWYONAOPH-UHFFFAOYSA-N 0.000 description 1
- HMWIOHBJIAPSEZ-UHFFFAOYSA-N [3-(2-fluoro-4-methoxyphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound FC1=CC(OC)=CC=C1C1=NSC(C(F)(F)F)=C1COS(C)(=O)=O HMWIOHBJIAPSEZ-UHFFFAOYSA-N 0.000 description 1
- DHKXKFBKLXHJKT-UHFFFAOYSA-N [3-(2-fluoro-4-methylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound FC1=CC(C)=CC=C1C1=NSC(C(F)(F)F)=C1COS(C)(=O)=O DHKXKFBKLXHJKT-UHFFFAOYSA-N 0.000 description 1
- NHEZVUAEFYDFCV-UHFFFAOYSA-N [3-(4-chlorophenyl)-5-methyl-1,2-thiazol-4-yl]methanol Chemical compound OCC1=C(C)SN=C1C1=CC=C(Cl)C=C1 NHEZVUAEFYDFCV-UHFFFAOYSA-N 0.000 description 1
- ZYHNHPPZEJGKFU-UHFFFAOYSA-N [3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methanol Chemical compound C1=CC(CC)=CC=C1C1=NSC(C(F)(F)F)=C1CO ZYHNHPPZEJGKFU-UHFFFAOYSA-N 0.000 description 1
- RNISHKNJZHUFHL-UHFFFAOYSA-N [3-(4-ethylphenyl)-5-methoxy-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound C1=CC(CC)=CC=C1C1=NSC(OC)=C1COS(C)(=O)=O RNISHKNJZHUFHL-UHFFFAOYSA-N 0.000 description 1
- CTZNBDMYAMKFDK-UHFFFAOYSA-N [3-(4-ethylphenyl)-5-phenyl-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound C1=CC(CC)=CC=C1C1=NSC(C=2C=CC=CC=2)=C1COS(C)(=O)=O CTZNBDMYAMKFDK-UHFFFAOYSA-N 0.000 description 1
- ZBJDXFDWNXCJGR-UHFFFAOYSA-N [3-(4-ethynylphenyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound CS(=O)(=O)OCC1=CSN=C1C1=CC=C(C#C)C=C1 ZBJDXFDWNXCJGR-UHFFFAOYSA-N 0.000 description 1
- WOVNLFZGMRLUAD-UHFFFAOYSA-N [3-(6-methoxypyridin-3-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound C1=NC(OC)=CC=C1C1=NSC(C(F)(F)F)=C1COS(C)(=O)=O WOVNLFZGMRLUAD-UHFFFAOYSA-N 0.000 description 1
- OSVOQOUBAKMQTL-UHFFFAOYSA-N [3-chloro-5-(4-chlorophenyl)-1,2-thiazol-4-yl]methanol Chemical compound ClC1=NSC(C=2C=CC(Cl)=CC=2)=C1CO OSVOQOUBAKMQTL-UHFFFAOYSA-N 0.000 description 1
- YIOIQBYHBIXPLE-UHFFFAOYSA-N [3-cyclopentyl-5-(trifluoromethyl)-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound S1C(C(F)(F)F)=C(COS(=O)(=O)C)C(C2CCCC2)=N1 YIOIQBYHBIXPLE-UHFFFAOYSA-N 0.000 description 1
- LKALZOIFRDLZRV-UHFFFAOYSA-N [5-(trifluoromethyl)-3-[4-(trifluoromethyl)phenyl]-1,2-thiazol-4-yl]methyl methanesulfonate Chemical compound S1C(C(F)(F)F)=C(COS(=O)(=O)C)C(C=2C=CC(=CC=2)C(F)(F)F)=N1 LKALZOIFRDLZRV-UHFFFAOYSA-N 0.000 description 1
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000569 acute exposure Toxicity 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 229960000250 adipic acid Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004909 aminosalicylic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000008365 aqueous carrier Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- OISFUZRUIGGTSD-LJTMIZJLSA-N azane;(2r,3r,4r,5s)-6-(methylamino)hexane-1,2,3,4,5-pentol Chemical compound N.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO OISFUZRUIGGTSD-LJTMIZJLSA-N 0.000 description 1
- 125000005603 azodicarboxylic group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 102000000072 beta-Arrestins Human genes 0.000 description 1
- 108010080367 beta-Arrestins Proteins 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940084891 byetta Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 229940095643 calcium hydroxide Drugs 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000009787 cardiac fibrosis Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004296 chiral HPLC Methods 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229940090805 clavulanate Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- WLVKDFJTYKELLQ-UHFFFAOYSA-N cyclopropylboronic acid Chemical compound OB(O)C1CC1 WLVKDFJTYKELLQ-UHFFFAOYSA-N 0.000 description 1
- DEZRYPDIMOWBDS-UHFFFAOYSA-N dcm dichloromethane Chemical compound ClCCl.ClCCl DEZRYPDIMOWBDS-UHFFFAOYSA-N 0.000 description 1
- 229960002887 deanol Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- ACYGYJFTZSAZKR-UHFFFAOYSA-J dicalcium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O ACYGYJFTZSAZKR-UHFFFAOYSA-J 0.000 description 1
- GRTGGSXWHGKRSB-UHFFFAOYSA-N dichloromethyl methyl ether Chemical compound COC(Cl)Cl GRTGGSXWHGKRSB-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- STRNXFOUBFLVIN-UHFFFAOYSA-N diethyl but-2-ynedioate Chemical compound CCOC(=O)C#CC(=O)OCC STRNXFOUBFLVIN-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- JMRYOSQOYJBDOI-UHFFFAOYSA-N dilithium;di(propan-2-yl)azanide Chemical compound [Li+].CC(C)[N-]C(C)C.CC(C)N([Li])C(C)C JMRYOSQOYJBDOI-UHFFFAOYSA-N 0.000 description 1
- SPCNPOWOBZQWJK-UHFFFAOYSA-N dimethoxy-(2-propan-2-ylsulfanylethylsulfanyl)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)SCCSC(C)C SPCNPOWOBZQWJK-UHFFFAOYSA-N 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- CETRZFQIITUQQL-UHFFFAOYSA-N dmso dimethylsulfoxide Chemical compound CS(C)=O.CS(C)=O CETRZFQIITUQQL-UHFFFAOYSA-N 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940029980 drug used in diabetes Drugs 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 229940009662 edetate Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 229950005627 embonate Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 208000028208 end stage renal disease Diseases 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229950000206 estolate Drugs 0.000 description 1
- LHWWETDBWVTKJO-UHFFFAOYSA-N et3n triethylamine Chemical compound CCN(CC)CC.CCN(CC)CC LHWWETDBWVTKJO-UHFFFAOYSA-N 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- LJQKCYFTNDAAPC-UHFFFAOYSA-N ethanol;ethyl acetate Chemical compound CCO.CCOC(C)=O LJQKCYFTNDAAPC-UHFFFAOYSA-N 0.000 description 1
- PSTNFOLOXKWXTL-FPYGCLRLSA-N ethyl (E)-3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]prop-2-enoate Chemical compound FC1=CC(/C=C/C(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 PSTNFOLOXKWXTL-FPYGCLRLSA-N 0.000 description 1
- FWOQDJIOLJLCRF-ARJAWSKDSA-N ethyl (Z)-3-(3,5-difluoro-4-hydroxyphenyl)prop-2-enoate Chemical compound CCOC(=O)\C=C/C1=CC(F)=C(O)C(F)=C1 FWOQDJIOLJLCRF-ARJAWSKDSA-N 0.000 description 1
- JUBQZHMAUZMXLU-GQCTYLIASA-N ethyl (e)-3-(4-hydroxy-1-benzothiophen-7-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(O)C2=C1SC=C2 JUBQZHMAUZMXLU-GQCTYLIASA-N 0.000 description 1
- MSSMYWLRSAAZNX-CSKARUKUSA-N ethyl (e)-3-(4-hydroxynaphthalen-1-yl)prop-2-enoate Chemical compound C1=CC=C2C(/C=C/C(=O)OCC)=CC=C(O)C2=C1 MSSMYWLRSAAZNX-CSKARUKUSA-N 0.000 description 1
- FOMGQKKTASTBNA-VQHVLOKHSA-N ethyl (e)-3-(7-hydroxy-2,3-dihydro-1h-inden-4-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(O)C2=C1CCC2 FOMGQKKTASTBNA-VQHVLOKHSA-N 0.000 description 1
- DEBRPFPPQOLLGQ-UHFFFAOYSA-N ethyl 2-(3,5-difluoro-4-hydroxyphenyl)cyclopropane-1-carboxylate Chemical compound CCOC(=O)C1CC1C1=CC(F)=C(O)C(F)=C1 DEBRPFPPQOLLGQ-UHFFFAOYSA-N 0.000 description 1
- LUQBNOJILQNJMS-UHFFFAOYSA-N ethyl 2-(4-hydroxyphenyl)cyclopropane-1-carboxylate Chemical compound CCOC(=O)C1CC1C1=CC=C(O)C=C1 LUQBNOJILQNJMS-UHFFFAOYSA-N 0.000 description 1
- VCSMNPSJHISWNB-UHFFFAOYSA-N ethyl 3-(2,6-difluoro-4-hydroxy-3-methylphenyl)propanoate Chemical compound CCOC(=O)CCC1=C(F)C=C(O)C(C)=C1F VCSMNPSJHISWNB-UHFFFAOYSA-N 0.000 description 1
- DQRGLCLEGSZGSN-UHFFFAOYSA-N ethyl 3-(2-ethyl-4-hydroxyphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C=C1CC DQRGLCLEGSZGSN-UHFFFAOYSA-N 0.000 description 1
- WYXYACZYFHYCAC-UHFFFAOYSA-N ethyl 3-(3,5-dibromo-4-hydroxyphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC(Br)=C(O)C(Br)=C1 WYXYACZYFHYCAC-UHFFFAOYSA-N 0.000 description 1
- NZRVUWDDVNJOHS-UHFFFAOYSA-N ethyl 3-(3-fluoro-4-hydroxyphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C(F)=C1 NZRVUWDDVNJOHS-UHFFFAOYSA-N 0.000 description 1
- UYFKNJKVUOKWSK-UHFFFAOYSA-N ethyl 3-(4-ethylphenyl)-5-(1,1,2,2,2-pentafluoroethyl)-1,2-thiazole-4-carboxylate Chemical compound S1C(C(F)(F)C(F)(F)F)=C(C(=O)OCC)C(C=2C=CC(CC)=CC=2)=N1 UYFKNJKVUOKWSK-UHFFFAOYSA-N 0.000 description 1
- TXHKPFVIRMWRNZ-UHFFFAOYSA-N ethyl 3-(4-hydroxy-3-methylphenyl)propanoate Chemical compound CCOC(=O)CCC1=CC=C(O)C(C)=C1 TXHKPFVIRMWRNZ-UHFFFAOYSA-N 0.000 description 1
- LGGICFDCAXCCSD-UHFFFAOYSA-N ethyl 3-(4-hydroxynaphthalen-1-yl)propanoate Chemical compound C1=CC=C2C(CCC(=O)OCC)=CC=C(O)C2=C1 LGGICFDCAXCCSD-UHFFFAOYSA-N 0.000 description 1
- UKIVNXCBKLKXTH-UHFFFAOYSA-N ethyl 3-[3,5-difluoro-4-[[3-(4-methoxyphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(OC)C=C1 UKIVNXCBKLKXTH-UHFFFAOYSA-N 0.000 description 1
- GKSCRADUMPZZFY-UHFFFAOYSA-N ethyl 3-[3,5-difluoro-4-[[3-(6-methoxypyridin-3-yl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(OC)N=C1 GKSCRADUMPZZFY-UHFFFAOYSA-N 0.000 description 1
- HGCBPCBAOXYHMU-UHFFFAOYSA-N ethyl 3-[3,5-difluoro-4-[[3-methoxy-5-(4-methoxyphenyl)-1,2-thiazol-4-yl]methoxy]phenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C=2C=CC(OC)=CC=2)SN=C1OC HGCBPCBAOXYHMU-UHFFFAOYSA-N 0.000 description 1
- QZFRHALSPMJCQW-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoate Chemical compound FC1=C(F)C(CCC(=O)OCC)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 QZFRHALSPMJCQW-UHFFFAOYSA-N 0.000 description 1
- PYDDOVHNAUUIRG-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluoro-2-methylphenyl]propanoate Chemical compound FC1=C(C)C(CCC(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 PYDDOVHNAUUIRG-UHFFFAOYSA-N 0.000 description 1
- HRKMPTIDSLHPLL-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoate Chemical compound FC1=CC(CC(C)C(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 HRKMPTIDSLHPLL-UHFFFAOYSA-N 0.000 description 1
- FFBNUADTANKCTK-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoate Chemical compound CCOC(=O)CCc1cc(F)c(OCc2c(nsc2C(F)(F)F)-c2ccc(Cl)cc2)c(F)c1 FFBNUADTANKCTK-UHFFFAOYSA-N 0.000 description 1
- RKAXQNFZQUGUPK-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-chlorophenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-methylphenyl]propanoate Chemical compound C1=C(C)C(CCC(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(Cl)C=C1 RKAXQNFZQUGUPK-UHFFFAOYSA-N 0.000 description 1
- LXEUARFQTQYXMO-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoate Chemical compound FC1=C(F)C(CCC(=O)OCC)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(CC)C=C1 LXEUARFQTQYXMO-UHFFFAOYSA-N 0.000 description 1
- PSZXUGYFSQSQMN-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]-2-methylpropanoate Chemical compound FC1=CC(CC(C)C(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(CC)C=C1 PSZXUGYFSQSQMN-UHFFFAOYSA-N 0.000 description 1
- VXRWGKLSZRZFJF-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(CC)C=C1 VXRWGKLSZRZFJF-UHFFFAOYSA-N 0.000 description 1
- LBYOTOUUNRWFCJ-UHFFFAOYSA-N ethyl 3-[4-[[3-(4-ethylphenyl)-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3-fluorophenyl]-2-methylpropanoate Chemical compound FC1=CC(CC(C)C(=O)OCC)=CC=C1OCC1=C(C(F)(F)F)SN=C1C1=CC=C(CC)C=C1 LBYOTOUUNRWFCJ-UHFFFAOYSA-N 0.000 description 1
- VUOBRSBCUZOTCG-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(2,4-dimethylphenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C=2C(=CC(C)=CC=2)C)SN=C1Cl VUOBRSBCUZOTCG-UHFFFAOYSA-N 0.000 description 1
- ARYAMVHLIZNYIP-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-5-ethyl-2-(trifluoromethyl)phenyl]propanoate Chemical compound C1=C(C(F)(F)F)C(CCC(=O)OCC)=CC(CC)=C1OCC1=C(C=2C(=CC=CC=2)C)SN=C1Cl ARYAMVHLIZNYIP-UHFFFAOYSA-N 0.000 description 1
- CYFGTPDFXXWLSC-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-5-fluoro-2-(trifluoromethyl)phenyl]propanoate Chemical compound C1=C(C(F)(F)F)C(CCC(=O)OCC)=CC(F)=C1OCC1=C(C=2C(=CC=CC=2)C)SN=C1Cl CYFGTPDFXXWLSC-UHFFFAOYSA-N 0.000 description 1
- QJXCBQWOOIJMQR-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(2-methylphenyl)-1,2-thiazol-4-yl]methoxy]-5-methyl-2-(trifluoromethyl)phenyl]propanoate Chemical compound C1=C(C(F)(F)F)C(CCC(=O)OCC)=CC(C)=C1OCC1=C(C=2C(=CC=CC=2)C)SN=C1Cl QJXCBQWOOIJMQR-UHFFFAOYSA-N 0.000 description 1
- ZQNWUYGJZZTMMP-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-chlorophenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoate Chemical compound FC1=C(F)C(CCC(=O)OCC)=CC=C1OCC1=C(C=2C=CC(Cl)=CC=2)SN=C1Cl ZQNWUYGJZZTMMP-UHFFFAOYSA-N 0.000 description 1
- DDUIQAYLKPIZBQ-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-ethylphenyl)-1,2-thiazol-4-yl]methoxy]-2,3,5-trifluorophenyl]propanoate Chemical compound FC1=C(F)C(CCC(=O)OCC)=CC(F)=C1OCC1=C(C=2C=CC(CC)=CC=2)SN=C1Cl DDUIQAYLKPIZBQ-UHFFFAOYSA-N 0.000 description 1
- QNJDTTDWGVACDY-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-ethylphenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoate Chemical compound FC1=C(F)C(CCC(=O)OCC)=CC=C1OCC1=C(C=2C=CC(CC)=CC=2)SN=C1Cl QNJDTTDWGVACDY-UHFFFAOYSA-N 0.000 description 1
- CHDCYZDSNYUSKE-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-ethylphenyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoate Chemical compound CC1=C(C)C(CCC(=O)OCC)=CC=C1OCC1=C(C=2C=CC(CC)=CC=2)SN=C1Cl CHDCYZDSNYUSKE-UHFFFAOYSA-N 0.000 description 1
- WXDUSMIIUDPLGF-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-ethylphenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C=2C=CC(CC)=CC=2)SN=C1Cl WXDUSMIIUDPLGF-UHFFFAOYSA-N 0.000 description 1
- QOYWFTYQWXYOJA-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-methoxyphenyl)-1,2-thiazol-4-yl]methoxy]-2,3-difluorophenyl]propanoate Chemical compound FC1=C(F)C(CCC(=O)OCC)=CC=C1OCC1=C(C=2C=CC(OC)=CC=2)SN=C1Cl QOYWFTYQWXYOJA-UHFFFAOYSA-N 0.000 description 1
- IGSVKTICXFWJMA-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-methoxyphenyl)-1,2-thiazol-4-yl]methoxy]-2,3-dimethylphenyl]propanoate Chemical compound CC1=C(C)C(CCC(=O)OCC)=CC=C1OCC1=C(C=2C=CC(OC)=CC=2)SN=C1Cl IGSVKTICXFWJMA-UHFFFAOYSA-N 0.000 description 1
- ZEEUJNYWHMTGCO-UHFFFAOYSA-N ethyl 3-[4-[[3-chloro-5-(4-methoxyphenyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C=2C=CC(OC)=CC=2)SN=C1Cl ZEEUJNYWHMTGCO-UHFFFAOYSA-N 0.000 description 1
- PNJSDVFWIZVWOQ-UHFFFAOYSA-N ethyl 3-[4-[[3-cyclopentyl-5-(trifluoromethyl)-1,2-thiazol-4-yl]methoxy]-3,5-difluorophenyl]propanoate Chemical compound FC1=CC(CCC(=O)OCC)=CC(F)=C1OCC1=C(C(F)(F)F)SN=C1C1CCCC1 PNJSDVFWIZVWOQ-UHFFFAOYSA-N 0.000 description 1
- BXBRFSMPBOTZHJ-UHFFFAOYSA-N ethyl 3-oxocyclobutane-1-carboxylate Chemical compound CCOC(=O)C1CC(=O)C1 BXBRFSMPBOTZHJ-UHFFFAOYSA-N 0.000 description 1
- NGLHQHAKQILQGD-UHFFFAOYSA-N ethyl 4-oxopent-2-ynoate Chemical compound CCOC(=O)C#CC(C)=O NGLHQHAKQILQGD-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000003784 fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229940050411 fumarate Drugs 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229960001731 gluceptate Drugs 0.000 description 1
- KWMLJOLKUYYJFJ-VFUOTHLCSA-N glucoheptonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O KWMLJOLKUYYJFJ-VFUOTHLCSA-N 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 229940049906 glutamate Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000003979 granulating agent Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 125000002636 imidazolinyl group Chemical group 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229950000077 iodol Drugs 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 1
- 229940011051 isopropyl acetate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 229940090473 januvia Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 229940099584 lactobionate Drugs 0.000 description 1
- JYTUSYBCFIZPBE-AMTLMPIISA-N lactobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-AMTLMPIISA-N 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 230000004576 lipid-binding Effects 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 229940098895 maleic acid Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N mandelic acid Chemical compound OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- 238000003328 mesylation reaction Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- GQJCAQADCPTHKN-UHFFFAOYSA-N methyl 2,2-difluoro-2-fluorosulfonylacetate Chemical compound COC(=O)C(F)(F)S(F)(=O)=O GQJCAQADCPTHKN-UHFFFAOYSA-N 0.000 description 1
- IBUFNGTUGHYRMP-UHFFFAOYSA-N methyl 3-(3,5-dibromo-4-hydroxyphenyl)propanoate Chemical compound COC(=O)CCC1=CC(Br)=C(O)C(Br)=C1 IBUFNGTUGHYRMP-UHFFFAOYSA-N 0.000 description 1
- KTGCFXSELRVRFH-UHFFFAOYSA-N methyl 3-oxocyclopentane-1-carboxylate Chemical compound COC(=O)C1CCC(=O)C1 KTGCFXSELRVRFH-UHFFFAOYSA-N 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- LRMHVVPPGGOAJQ-UHFFFAOYSA-N methyl nitrate Chemical compound CO[N+]([O-])=O LRMHVVPPGGOAJQ-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- JZMJDSHXVKJFKW-UHFFFAOYSA-M methyl sulfate(1-) Chemical compound COS([O-])(=O)=O JZMJDSHXVKJFKW-UHFFFAOYSA-M 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 125000006578 monocyclic heterocycloalkyl group Chemical group 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- JKRHDMPWBFBQDZ-UHFFFAOYSA-N n'-hexylmethanediimine Chemical compound CCCCCCN=C=N JKRHDMPWBFBQDZ-UHFFFAOYSA-N 0.000 description 1
- PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
- LHWKGTYIUGLNRX-UHFFFAOYSA-N n-(2,6-diethylphenyl)thiophene-2-carboxamide Chemical compound CCC1=CC=CC(CC)=C1NC(=O)C1=CC=CS1 LHWKGTYIUGLNRX-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- PSACHCMMPFMFAJ-UHFFFAOYSA-N nmm n-methylmorpholine Chemical compound CN1CCOCC1.CN1CCOCC1 PSACHCMMPFMFAJ-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229960005010 orotic acid Drugs 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 229940014662 pantothenate Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000019371 penicillin G benzathine Nutrition 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- WSHYKIAQCMIPTB-UHFFFAOYSA-M potassium;2-oxo-3-(3-oxo-1-phenylbutyl)chromen-4-olate Chemical compound [K+].[O-]C=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 WSHYKIAQCMIPTB-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003072 pyrazolidinyl group Chemical group 0.000 description 1
- 125000002755 pyrazolinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 125000001422 pyrrolinyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940083608 sodium hydroxide Drugs 0.000 description 1
- LYPGDCWPTHTUDO-UHFFFAOYSA-M sodium;methanesulfinate Chemical compound [Na+].CS([O-])=O LYPGDCWPTHTUDO-UHFFFAOYSA-M 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229950002757 teoclate Drugs 0.000 description 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 150000003577 thiophenes Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000010875 transient cerebral ischemia Diseases 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 description 1
- LALRXNPLTWZJIJ-UHFFFAOYSA-N triethylborane Chemical compound CCB(CC)CC LALRXNPLTWZJIJ-UHFFFAOYSA-N 0.000 description 1
- 125000004360 trifluorophenyl group Chemical group 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- IIHPVYJPDKJYOU-UHFFFAOYSA-N triphenylcarbethoxymethylenephosphorane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=CC(=O)OCC)C1=CC=CC=C1 IIHPVYJPDKJYOU-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- UOHFCPXBKJPCAD-UHFFFAOYSA-N tyrphostin 1 Chemical compound COC1=CC=C(C=C(C#N)C#N)C=C1 UOHFCPXBKJPCAD-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940070710 valerate Drugs 0.000 description 1
- SYOKIDBDQMKNDQ-XWTIBIIYSA-N vildagliptin Chemical compound C1C(O)(C2)CC(C3)CC1CC32NCC(=O)N1CCC[C@H]1C#N SYOKIDBDQMKNDQ-XWTIBIIYSA-N 0.000 description 1
- 229960001254 vildagliptin Drugs 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D419/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2014/021775 WO2015134039A1 (en) | 2014-03-07 | 2014-03-07 | Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014385276A1 AU2014385276A1 (en) | 2016-09-01 |
| AU2014385276B2 true AU2014385276B2 (en) | 2019-01-17 |
Family
ID=50391464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014385276A Ceased AU2014385276B2 (en) | 2014-03-07 | 2014-03-07 | Isothiazole derivatives as GPR120 agonists for the treatment of Type II diabetes |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP3114123B1 (https=) |
| JP (1) | JP6303031B2 (https=) |
| CN (1) | CN106414434B (https=) |
| AU (1) | AU2014385276B2 (https=) |
| CA (1) | CA2941445A1 (https=) |
| ES (2) | ES2887011T3 (https=) |
| MX (1) | MX367852B (https=) |
| WO (1) | WO2015134039A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2944572T3 (es) | 2016-03-15 | 2023-06-22 | Univ London Queen Mary | Procedimiento de tratamiento de la obesidad |
| JP6809278B2 (ja) * | 2017-02-17 | 2021-01-06 | Jnc株式会社 | 重合性液晶化合物、重合性液晶組成物および液晶重合膜 |
| JP2021517142A (ja) | 2018-03-15 | 2021-07-15 | アクザム ソシエタ ペル アチオニ | 置換ピラゾールffa4/gpr120受容体作動薬 |
| CN118040044B (zh) * | 2023-11-07 | 2024-09-13 | 南昌大学 | 一种电解液与锂离子电池 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010048207A2 (en) * | 2008-10-21 | 2010-04-29 | Metabolex, Inc. | Aryl gpr120 receptor agonists and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999011255A1 (en) * | 1997-08-28 | 1999-03-11 | Ono Pharmaceutical Co., Ltd. | Peroxisome proliferator-activated receptor controllers |
| JP4594611B2 (ja) * | 2002-11-08 | 2010-12-08 | 武田薬品工業株式会社 | 受容体機能調節剤 |
| GB0405033D0 (en) * | 2004-03-05 | 2004-04-07 | Karobio Ab | Novel pharmaceutical compositions |
| AR074760A1 (es) * | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| CN105209446A (zh) * | 2013-03-14 | 2015-12-30 | 詹森药业有限公司 | 用于治疗ii型糖尿病的gpr120激动剂 |
-
2014
- 2014-03-07 CN CN201480078670.3A patent/CN106414434B/zh not_active Expired - Fee Related
- 2014-03-07 MX MX2016011630A patent/MX367852B/es active IP Right Grant
- 2014-03-07 JP JP2016573458A patent/JP6303031B2/ja not_active Expired - Fee Related
- 2014-03-07 AU AU2014385276A patent/AU2014385276B2/en not_active Ceased
- 2014-03-07 CA CA2941445A patent/CA2941445A1/en not_active Abandoned
- 2014-03-07 ES ES18169025T patent/ES2887011T3/es active Active
- 2014-03-07 WO PCT/US2014/021775 patent/WO2015134039A1/en not_active Ceased
- 2014-03-07 ES ES14714057.8T patent/ES2673578T3/es active Active
- 2014-03-07 EP EP14714057.8A patent/EP3114123B1/en not_active Not-in-force
- 2014-03-07 EP EP18169025.6A patent/EP3409671B1/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010048207A2 (en) * | 2008-10-21 | 2010-04-29 | Metabolex, Inc. | Aryl gpr120 receptor agonists and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2887011T3 (es) | 2021-12-21 |
| CN106414434B (zh) | 2019-12-31 |
| EP3409671B1 (en) | 2021-07-21 |
| JP6303031B2 (ja) | 2018-03-28 |
| MX2016011630A (es) | 2016-11-29 |
| JP2017507189A (ja) | 2017-03-16 |
| EP3114123B1 (en) | 2018-04-25 |
| AU2014385276A1 (en) | 2016-09-01 |
| EP3409671A1 (en) | 2018-12-05 |
| CA2941445A1 (en) | 2015-09-11 |
| ES2673578T3 (es) | 2018-06-22 |
| WO2015134039A1 (en) | 2015-09-11 |
| EP3114123A1 (en) | 2017-01-11 |
| MX367852B (es) | 2019-09-09 |
| CN106414434A (zh) | 2017-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014241390B2 (en) | GPR120 agonists for the treatment of type II diabetes | |
| JP6853619B2 (ja) | シアノトリアゾール化合物の医薬用途 | |
| RU2527948C2 (ru) | Новый агонист бета рецептора тиреоидного гормона | |
| JP5043105B2 (ja) | 有機化合物 | |
| US9067898B1 (en) | Isothiazole derivatives as GPR120 agonists for the treatment of type II diabetes | |
| JP2017522277A (ja) | 代謝型グルタミン酸受容体の負のアロステリックモジュレーター(nams)とその使用 | |
| JP2017530986A (ja) | 2型糖尿病治療のためのgpr40アゴニストとしての置換ベンゾチオフェニル誘導体 | |
| WO2017180571A1 (en) | Substituted benzothiophenyl derivatives as gpr40 agonists for the treatment of type ii diabetes | |
| AU2014385276B2 (en) | Isothiazole derivatives as GPR120 agonists for the treatment of Type II diabetes | |
| AU2019293727B2 (en) | Novel LXR modulators with bicyclic core moiety | |
| KR102372599B1 (ko) | Rxr 아고니스트로서의 치환 바이시클릭 헤테로아릴 화합물 | |
| KR20240072145A (ko) | 트리아졸론 화합물 및 이의 의학적 용도 | |
| JPWO2012081570A1 (ja) | ラクタム化合物又はその塩及びppar活性化剤 | |
| EP2521727B1 (fr) | Nouveaux dérivés pyrrolopyridine benzoïques et leur utilisation pour le traitement de la maladie de parkinson | |
| KR20080032155A (ko) | 페록시좀 증식제 활성화 수용체 δ 의 활성화제 | |
| HK40005165A (en) | Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes | |
| HK40005165B (en) | Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes | |
| HK1233634A1 (en) | Isothiazole derivatives as gpr120 agonists for the treatment of type ii diabetes | |
| HK1233634B (zh) | 异噻唑衍生物作为用於治疗ii型糖尿病的gpr120激动剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |